DOCSLIB.ORG

Written Evidence Submitted by the Wellcome Sanger Institute (C190066)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Written Evidence Submitted by the Wellcome Sanger Institute (C190066) Written Evidence Submitted by the Wellcome Sanger Institute (C190066) Introduction 1. The Wellcome Sanger Institute uses genomics to advance the understanding of human and pathogen biology to improve human health. We use science at scale to tackle the most challenging global health research questions. 2. The Wellcome Sanger Institute is based on the Wellcome Genome Campus: a world-leading hub for genomes and biodata research. The campus is also home to EMBL-EBI, Connecting Science, Genomics England and several spin-out and start-up companies. Key Messages 3. Thanks to an advanced national genomics sector, the UK was ideally placed to rapidly reposition to launch and deliver a genomic strategy to help combat COVID-19. Established practices of collaboration and transparency in genomics enabled the swift launch of the COVID-19 Genomics UK Consortium (COG- UK) and its subsequent speedy provision of real-world evidence to inform public health interventions. 4. Continued investment in scientific research and infrastructure by successive governments and UK research charities has enabled the development of invaluable scientific resources, such as the Human Cell Atlas, which have been rapidly utilised and repurposed to tackle COVID-19. 5. Medical research charities play an integral role in UK research, but have suffered financially during this global health crisis. Financial support for medical research charities is not only vital for mitigating the impacts of the pandemic but for protecting and maintaining the UK’s research sector which is reliant on the medical research charities. 6. Public-private partnerships can be an excellent vehicle for the advancement of basic science from the laboratory into healthcare. Opportunities to collaborate across the academic, commercial and healthcare sectors should be incentivised to accelerate the development of healthcare interventions. 7. The Health Research Authority’s (HRA) rigorous and efficient fast-track system for approving COVID-19 research studies was hugely beneficial and reflects the UK’s responsive and pragmatic approach to research regulation. 8. The free and unrestricted sharing of SARS-CoV-2 genomic data has been enormously important for public health efforts. It is vital that regulations to support access and benefit sharing, such as the Nagoya Protocol, do not hinder or prevent data sharing during pandemics. 9. Difficulties obtaining metadata and the use of different data standards are major challenges with the large-scale sequencing projects and can reduce the overall effectiveness of interpreting the SARS-CoV-2 genome and identifying localised outbreaks. Initiatives such as HDR-UK and use of recognised data standards, such as those created by the Global Alliance for Genomics and Health (GA4GH), can support the open sharing of data and knowledge to ensure fair and equitable access to scientific research. 10. Efficient and effective data connectivity is vital in creating a consolidated UK-wide COVID-19 dataset. Efforts to reduce data fragmentation and improve data connectivity will revolutionise our scientific understanding of human health and disease. The contribution of R&D in understanding SARS-CoV-2 transmission and epidemiology 11. Rapid scientific insights have been invaluable in tackling the global COVID-19 pandemic by guiding public health responses and driving the development of vaccines and therapeutics. The Sanger Institute is uniquely positioned within the UK research landscape to provide globally recognised expertise and infrastructure in pathogen surveillance and large-scale, high-throughput genome sequencing to strengthen COVID-19 research efforts. The Sanger Institute rapidly refocused its research towards understanding the biology and evolution of the SARS-CoV-2 virus, tracking its transmission and deciphering its interactions with human cells. 12. To identify SARS-CoV-2-infected individuals in large populations globally, diagnostic tests must be rapid, accurate, scalable, portable and available at a low-cost. In collaboration with UCL and the Universities of Oxford and Cambridge, the Bassett and Teichmann labs at the Sanger Institute have developed INSIGHT – a 2-stage COVID-19 testing strategy that is designed to detect SARS-CoV-2 in a highly specific manner from human saliva in 1-2 hours via fluorescence detection or a dipstick readout1. Unique barcodes can be added to samples to enable the monitoring of viral mutations and transmission among populations. COVID-19 Genomics UK Consortium (COG-UK) – coming together to tackle a public health challenge 13. COG-UK is an innovative partnership connecting leaders in genomics and public health across the interface of government, public health and academia2. Led by Prof Sharon Peacock, COG-UK brings together NHS organisations, the four UK Public Health Agencies, multiple university hubs and sequencing centres, including the Sanger Institute, to deliver rapid and large-scale sequencing of the SARS-CoV-2 virus. 14. Supported by £20 million funding from the Department of Health and Social Care, UK Research and Innovation (UKRI) and Wellcome, COG-UK is performing rapid and large-scale sequencing of SARS-CoV-2 to understand its transmission and epidemiology, the emergence of resistance mutations and to identify genetic markers associated with clinical severity. 15. The complex network of COG-UK was set up rapidly. With experts in pathogen surveillance and high- throughput genomics sequencing and a history of large-scale and rapid whole genome sequencing, the Sanger Institute was ideally placed to aid the UK government’s public health response to the COVID-19 epidemic. Viral samples were collected from the national testing centres and NHS and public health laboratories and then whole genome sequenced at regional laboratories and at the Sanger Institute. COG-UK delivered its first report to the UK government Scientific Advisory Group for Emergencies (SAGE) based on 260 SARS-CoV-2 genome sequences less than a fortnight after the initial COG-UK meeting. As of July 2020, COG-UK has sequenced 30,000 SARS-CoV-2 genomes, 9,000 of which were sequenced at the Sanger Institute. The Sanger Institute now has the capacity to receive 300,000 samples per week from the Lighthouse Laboratories and cherry pick the positive samples to sequence up to 1,000 SARS- CoV-2 genomes a day. 16. COG-UK data is made freely available to the research community as quickly as possible and according to the FAIR3 principles. COG-UK sequencing of SARS-CoV-2 has revealed there were 1356 sources of SARS- CoV-2 introductions into the UK during March 20204. Each of these viral introductions was transmitted onwards within the UK. 1 https://www.biorxiv.org/content/10.1101/2020.06.01.127019v1 2 https://www.cogconsortium.uk/ 3 https://www.nature.com/articles/sdata201618 Human Cell Atlas (HCA) – rapid repurposing of flagship science 17. HCA is a grass-roots international consortium creating a comprehensive reference map of all human cells to understand human health and disease5. Launched in 2016, HCA has already delivered projects to understand human biology including the immune system, nervous system, the gut and cancer. In response to the COVID-19 pandemic, the HCA community has rapidly refocused efforts to deepen our understanding of COVID-19 and transmission routes of SARS-CoV-2. 18. Existing HCA datasets were analysed to identify cells expressing key host proteins exploited by SARS- CoV-2 to enter human cells. Two types of cell in the nose were found to have the highest levels of these host proteins and are the likely infection route into the human body for the virus6. Over 1 million cells in nasal, airway and lung samples were then analysed to understand clinical outcomes and risk factors. A number of potential therapeutic targets were found and smokers and men were identified as being more susceptible to COVID-19 infection7. Open Targets – novel drug target identification for COVID-19 19. Open Targets is a precompetitive public-private partnership between the Sanger Institute, EMBL-EBI, GSK, Takeda, Celgene and Sanofi that uses genomics to identify and prioritise drug targets8. 20. Open Targets have developed a COVID-19 Target Prioritisation Tool, which has identified 261 potential host and virus drug targets associated with COVID-19. There are plans to integrate the tool with the EU COVID-19 Data Platform. The impact of COVID-19 on research funding 21. The Sanger Institute receives funding from Wellcome in the form of a core grant and is further supported by external grants from funders including UK Research Councils, charities and European and international funders. The Institute benefits from working in a well and diversely funded science ecosystem. 22. Half of publically funded medical research in the UK is funded by medical charities and during the COVID- 19 pandemic this sector has experienced a 38% loss in their fundraising income and charities have had to cut or cancel 18% of their spend on research in universities9. The immediate and long-term impact on medical research funding in the UK will be catastrophic and the sector has estimated that it will take approximately 4.5 years for their medical research spending to recover to normal levels. Reduced funding will stifle medical research, delay scientific breakthroughs and hinder the initiation and completion of clinical trials. This will negatively impact all parts of UK R&D whether funded directly by medical research charities or not. The flexibility of regulatory and ethical processes during the
Load more

Recommended publications
  • Analysis of the Impact of Sequencing Errors on Blast Using Fault Injection
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Illinois Digital Environment for Access to Learning and Scholarship Repository ANALYSIS OF THE IMPACT OF SEQUENCING ERRORS ON BLAST USING FAULT INJECTION BY SO YOUN LEE THESIS Submitted in partial fulfillment of the requirements for the degree of Master of Science in Electrical and Computer Engineering in the Graduate College of the University of Illinois at Urbana-Champaign, 2013 Urbana, Illinois Adviser: Professor Ravishankar K. Iyer ABSTRACT This thesis investigates the impact of sequencing errors in post-sequence computational analyses, including local alignment search and multiple sequence alignment. While the error rates of sequencing technology are commonly reported, the significance of these numbers cannot be fully grasped without putting them in the perspective of their impact on the downstream analyses that are used for biological research, forensics, diagnosis of diseases, etc. I approached the quantification of the impact using fault injection. Faults were injected in the input sequence data, and the analyses were run. Change in the output of the analyses was interpreted as the impact of faults, or errors. Three commonly used algorithms were used: BLAST, SSEARCH, and ProbCons. The main contributions of this work are the application of fault injection to the reliability analysis in bioinformatics and the quantitative demonstration that a small error rate in the sequence data can alter the output of the analysis in a significant way. BLAST and SSEARCH are both local alignment search tools, but BLAST is a heuristic implementation, while SSEARCH is based on the optimal Smith-Waterman algorithm.
    [Show full text]
  • Advancing Solutions to the Carbohydrate Sequencing Challenge † † † ‡ § Christopher J
    Perspective Cite This: J. Am. Chem. Soc. 2019, 141, 14463−14479 pubs.acs.org/JACS Advancing Solutions to the Carbohydrate Sequencing Challenge † † † ‡ § Christopher J. Gray, Lukasz G. Migas, Perdita E. Barran, Kevin Pagel, Peter H. Seeberger, ∥ ⊥ # ⊗ ∇ Claire E. Eyers, Geert-Jan Boons, Nicola L. B. Pohl, Isabelle Compagnon, , × † Göran Widmalm, and Sabine L. Flitsch*, † School of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester M1 7DN, U.K. ‡ Institute for Chemistry and Biochemistry, Freie Universitaẗ Berlin, Takustraße 3, 14195 Berlin, Germany § Biomolecular Systems Department, Max Planck Institute for Colloids and Interfaces, Am Muehlenberg 1, 14476 Potsdam, Germany ∥ Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 7ZB, U.K. ⊥ Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, United States # Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States ⊗ Institut Lumierè Matiere,̀ UMR5306 UniversitéLyon 1-CNRS, Universitéde Lyon, 69622 Villeurbanne Cedex, France ∇ Institut Universitaire de France IUF, 103 Blvd St Michel, 75005 Paris, France × Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, S-106 91 Stockholm, Sweden *S Supporting Information established connection between their structure and their ABSTRACT: Carbohydrates possess a variety of distinct function, full characterization of unknown carbohydrates features with
    [Show full text]
  • "Phylogenetic Analysis of Protein Sequence Data Using The
    Phylogenetic Analysis of Protein Sequence UNIT 19.11 Data Using the Randomized Axelerated Maximum Likelihood (RAXML) Program Antonis Rokas1 1Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee ABSTRACT Phylogenetic analysis is the study of evolutionary relationships among molecules, phenotypes, and organisms. In the context of protein sequence data, phylogenetic analysis is one of the cornerstones of comparative sequence analysis and has many applications in the study of protein evolution and function. This unit provides a brief review of the principles of phylogenetic analysis and describes several different standard phylogenetic analyses of protein sequence data using the RAXML (Randomized Axelerated Maximum Likelihood) Program. Curr. Protoc. Mol. Biol. 96:19.11.1-19.11.14. C 2011 by John Wiley & Sons, Inc. Keywords: molecular evolution r bootstrap r multiple sequence alignment r amino acid substitution matrix r evolutionary relationship r systematics INTRODUCTION the baboon-colobus monkey lineage almost Phylogenetic analysis is a standard and es- 25 million years ago, whereas baboons and sential tool in any molecular biologist’s bioin- colobus monkeys diverged less than 15 mil- formatics toolkit that, in the context of pro- lion years ago (Sterner et al., 2006). Clearly, tein sequence analysis, enables us to study degree of sequence similarity does not equate the evolutionary history and change of pro- with degree of evolutionary relationship. teins and their function. Such analysis is es- A typical phylogenetic analysis of protein sential to understanding major evolutionary sequence data involves five distinct steps: (a) questions, such as the origins and history of data collection, (b) inference of homology, (c) macromolecules, developmental mechanisms, sequence alignment, (d) alignment trimming, phenotypes, and life itself.
    [Show full text]
  • EMBL-EBI Powerpoint Presentation
    Processing data from high-throughput sequencing experiments Simon Anders Use-cases for HTS · de-novo sequencing and assembly of small genomes · transcriptome analysis (RNA-Seq, sRNA-Seq, ...) • identifying transcripted regions • expression profiling · Resequencing to find genetic polymorphisms: • SNPs, micro-indels • CNVs · ChIP-Seq, nucleosome positions, etc. · DNA methylation studies (after bisulfite treatment) · environmental sampling (metagenomics) · reading bar codes Use cases for HTS: Bioinformatics challenges Established procedures may not be suitable. New algorithms are required for · assembly · alignment · statistical tests (counting statistics) · visualization · segmentation · ... Where does Bioconductor come in? Several steps: · Processing of the images and determining of the read sequencest • typically done by core facility with software from the manufacturer of the sequencing machine · Aligning the reads to a reference genome (or assembling the reads into a new genome) • Done with community-developed stand-alone tools. · Downstream statistical analyis. • Write your own scripts with the help of Bioconductor infrastructure. Solexa standard workflow SolexaPipeline · "Firecrest": Identifying clusters ⇨ typically 15..20 mio good clusters per lane · "Bustard": Base calling ⇨ sequence for each cluster, with Phred-like scores · "Eland": Aligning to reference Firecrest output Large tab-separated text files with one row per identified cluster, specifying · lane index and tile index · x and y coordinates of cluster on tile · for each
    [Show full text]
  • A SARS-Cov-2 Sequence Submission Tool for the European Nucleotide
    Databases and ontologies Downloaded from https://academic.oup.com/bioinformatics/advance-article/doi/10.1093/bioinformatics/btab421/6294398 by guest on 25 June 2021 A SARS-CoV-2 sequence submission tool for the European Nucleotide Archive Miguel Roncoroni 1,2,∗, Bert Droesbeke 1,2, Ignacio Eguinoa 1,2, Kim De Ruyck 1,2, Flora D’Anna 1,2, Dilmurat Yusuf 3, Björn Grüning 3, Rolf Backofen 3 and Frederik Coppens 1,2 1Department of Plant Biotechnology and Bioinformatics, Ghent University, 9052 Ghent, Belgium, 1VIB Center for Plant Systems Biology, 9052 Ghent, Belgium and 2University of Freiburg, Department of Computer Science, Freiburg im Breisgau, Baden-Württemberg, Germany ∗To whom correspondence should be addressed. Associate Editor: XXXXXXX Received on XXXXX; revised on XXXXX; accepted on XXXXX Abstract Summary: Many aspects of the global response to the COVID-19 pandemic are enabled by the fast and open publication of SARS-CoV-2 genetic sequence data. The European Nucleotide Archive (ENA) is the European recommended open repository for genetic sequences. In this work, we present a tool for submitting raw sequencing reads of SARS-CoV-2 to ENA. The tool features a single-step submission process, a graphical user interface, tabular-formatted metadata and the possibility to remove human reads prior to submission. A Galaxy wrap of the tool allows users with little or no bioinformatic knowledge to do bulk sequencing read submissions. The tool is also packed in a Docker container to ease deployment. Availability: CLI ENA upload tool is available at github.com/usegalaxy- eu/ena-upload-cli (DOI 10.5281/zenodo.4537621); Galaxy ENA upload tool at toolshed.g2.bx.psu.edu/view/iuc/ena_upload/382518f24d6d and https://github.com/galaxyproject/tools- iuc/tree/master/tools/ena_upload (development) and; ENA upload Galaxy container at github.com/ELIXIR- Belgium/ena-upload-container (DOI 10.5281/zenodo.4730785) Contact: [email protected] 1 Introduction Nucleotide Archive (ENA).
    [Show full text]
  • Genomic Sequencing of SARS-Cov-2: a Guide to Implementation for Maximum Impact on Public Health
    Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2 A guide to implementation for maximum impact on public health 8 January 2021 Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health ISBN 978-92-4-001844-0 (electronic version) ISBN 978-92-4-001845-7 (print version) © World Health Organization 2021 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http://www.wipo.int/amc/en/mediation/rules/).
    [Show full text]
  • The Biogrid Interaction Database
    D470–D478 Nucleic Acids Research, 2015, Vol. 43, Database issue Published online 26 November 2014 doi: 10.1093/nar/gku1204 The BioGRID interaction database: 2015 update Andrew Chatr-aryamontri1, Bobby-Joe Breitkreutz2, Rose Oughtred3, Lorrie Boucher2, Sven Heinicke3, Daici Chen1, Chris Stark2, Ashton Breitkreutz2, Nadine Kolas2, Lara O’Donnell2, Teresa Reguly2, Julie Nixon4, Lindsay Ramage4, Andrew Winter4, Adnane Sellam5, Christie Chang3, Jodi Hirschman3, Chandra Theesfeld3, Jennifer Rust3, Michael S. Livstone3, Kara Dolinski3 and Mike Tyers1,2,4,* 1Institute for Research in Immunology and Cancer, Universite´ de Montreal,´ Montreal,´ Quebec H3C 3J7, Canada, 2The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada, 3Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA, 4School of Biological Sciences, University of Edinburgh, Edinburgh EH9 3JR, UK and 5Centre Hospitalier de l’UniversiteLaval´ (CHUL), Quebec,´ Quebec´ G1V 4G2, Canada Received September 26, 2014; Revised November 4, 2014; Accepted November 5, 2014 ABSTRACT semi-automated text-mining approaches, and to en- hance curation quality control. The Biological General Repository for Interaction Datasets (BioGRID: http://thebiogrid.org) is an open access database that houses genetic and protein in- INTRODUCTION teractions curated from the primary biomedical lit- Massive increases in high-throughput DNA sequencing erature for all major model organism species and technologies (1) have enabled an unprecedented level of humans. As of September 2014, the BioGRID con- genome annotation for many hundreds of species (2–6), tains 749 912 interactions as drawn from 43 149 pub- which has led to tremendous progress in the understand- lications that represent 30 model organisms.
    [Show full text]
  • The Interpro Database, an Integrated Documentation Resource for Protein
    The InterPro database, an integrated documentation resource for protein families, domains and functional sites R Apweiler, T K Attwood, A Bairoch, A Bateman, E Birney, M Biswas, P Bucher, L Cerutti, F Corpet, M D Croning, et al. To cite this version: R Apweiler, T K Attwood, A Bairoch, A Bateman, E Birney, et al.. The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Research, Oxford University Press, 2001, 29 (1), pp.37-40. 10.1093/nar/29.1.37. hal-01213150 HAL Id: hal-01213150 https://hal.archives-ouvertes.fr/hal-01213150 Submitted on 7 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. © 2001 Oxford University Press Nucleic Acids Research, 2001, Vol. 29, No. 1 37–40 The InterPro database, an integrated documentation resource for protein families, domains and functional sites R. Apweiler1,*, T. K. Attwood2,A.Bairoch3, A. Bateman4,E.Birney1, M. Biswas1, P. Bucher5, L. Cerutti4,F.Corpet6, M. D. R. Croning1,2, R. Durbin4,L.Falquet5,W.Fleischmann1, J. Gouzy6,H.Hermjakob1,N.Hulo3, I. Jonassen7,D.Kahn6,A.Kanapin1, Y. Karavidopoulou1, R.
    [Show full text]
  • Enabling Interpretation of Protein Variation Effects with Uniprot
    Andrew Nightingale1, Jie luo, Michele Magrane1, Peter McGarvey2, Sandra Orchard1, Maria Martin1, UniProt Consortium1,2,3 1EMBL-European Bioinformatics Institute, Cambridge, UK 2SIB Swiss Institute of Bioinformatics, Geneva, Switzerland 3Protein Information Resource, Georgetown University, Washington DC & University of Delaware, USA Enabling interpretation of protein variation effects with UniProt Introduction Understanding the effect of genetic variants on protein function is crucial to thoroughly understand the role of proteins in disease biology. UniProt aims to support the scientific community, computational biologists and clinical researchers, by providing a comprehensive, high-quality and freely accessible resource of protein sequence and functional information. This includes a comprehensive catalogue of protein altering variation data coupled with information about how these variants affect protein function. UniProt variant data sources Variant data from literature Large-scale variant data Variants are captured from the scientific 1. Imported variant literature and manually reviewed for data is dependent addition to UniProtKB/Swiss-Prot upon exact mapping between the reference proteome Description of disease associated with and genome. genetic variations in a protein TCGA 2. Variant data is imported from a variety of resources Variant data including effects of the variant Database Total Imported Variant Total Unique to complement the on the protein and links to variant 1000Genomes 859,757 81,216 resources ClinVar 183,655 76,218 set of variants COSMIC 184,237 18,863 Category Number ESP 939,238 68,803 captured from the ExAC 4,333,620 2,776,617 Total reviewed variants 79,284 TCGA 1,202,700 920,549 literature Disease-associated variants 30,471 UniProt 80,224 49,971 Total 7,781,431 3,992,437 Number of proteins with variants 12,886 *Represents the number of UniProt variants with a dbSNP identifier Interpretation protein variant effect with UniProt 1.
    [Show full text]
  • Genbank Is a Reliable Resource for 21St Century Biodiversity Research
    GenBank is a reliable resource for 21st century biodiversity research Matthieu Leraya, Nancy Knowltonb,1, Shian-Lei Hoc, Bryan N. Nguyenb,d,e, and Ryuji J. Machidac,1 aSmithsonian Tropical Research Institute, Smithsonian Institution, Panama City, 0843-03092, Republic of Panama; bNational Museum of Natural History, Smithsonian Institution, Washington, DC 20560; cBiodiversity Research Centre, Academia Sinica, 115-29 Taipei, Taiwan; dDepartment of Biological Sciences, The George Washington University, Washington, DC 20052; and eComputational Biology Institute, Milken Institute School of Public Health, The George Washington University, Washington, DC 20052 Contributed by Nancy Knowlton, September 15, 2019 (sent for review July 10, 2019; reviewed by Ann Bucklin and Simon Creer) Traditional methods of characterizing biodiversity are increasingly (13), the largest repository of genetic data for biodiversity (14, 15). being supplemented and replaced by approaches based on DNA In many cases, no vouchers are available to independently con- sequencing alone. These approaches commonly involve extraction firm identification, because the organisms are tiny, very difficult and high-throughput sequencing of bulk samples from biologically or impossible to identify, or lacking entirely (in the case of eDNA). complex communities or samples of environmental DNA (eDNA). In While concerns have been raised about biases and inaccuracies in such cases, vouchers for individual organisms are rarely obtained, often laboratory and analytical methods used in metabarcoding
    [Show full text]
  • Molecular Phylogenetics: Principles and Practice
    REVIEWS STUDY DESIGNS Molecular phylogenetics: principles and practice Ziheng Yang1,2 and Bruce Rannala1,3 Abstract | Phylogenies are important for addressing various biological questions such as relationships among species or genes, the origin and spread of viral infection and the demographic changes and migration patterns of species. The advancement of sequencing technologies has taken phylogenetic analysis to a new height. Phylogenies have permeated nearly every branch of biology, and the plethora of phylogenetic methods and software packages that are now available may seem daunting to an experimental biologist. Here, we review the major methods of phylogenetic analysis, including parsimony, distance, likelihood and Bayesian methods. We discuss their strengths and weaknesses and provide guidance for their use. statistical Systematics Before the advent of DNA sequencing technologies, phylogenetics, creating the emerging field of 2,18,19 The inference of phylogenetic phylogenetic trees were used almost exclusively to phylogeography. In species tree methods , the gene relationships among species describe relationships among species in systematics and trees at individual loci may not be of direct interest and and the use of such information taxonomy. Today, phylogenies are used in almost every may be in conflict with the species tree. By averaging to classify species. branch of biology. Besides representing the relation- over the unobserved gene trees under the multi-species 20 Taxonomy ships among species on the tree of life, phylogenies
    [Show full text]
  • BLAST Practice
    Using BLAST BLAST (Basic Local Alignment Search Tool) is an online search tool provided by NCBI (National Center for Biotechnology Information). It allows you to “find regions of similarity between biological sequences” (nucleotide or protein). The NCBI maintains a huge database of biological sequences, which it compares the query sequences to in order to find the most similar ones. Using BLAST, you can input a gene sequence of interest and search entire genomic libraries for identical or similar sequences in a matter of seconds. The amount of information on the BLAST website is a bit overwhelming — even for the scientists who use it on a frequent basis! You are not expected to know every detail of the BLAST program. BLAST results have the following fields: E value: The E value (expected value) is a number that describes how many times you would expect a match by chance in a database of that size. The lower the E value is, the more significant the match. Percent Identity: The percent identity is a number that describes how similar the query sequence is to the target sequence (how many characters in each sequence are identical). The higher the percent identity is, the more significant the match. Query Cover: The query cover is a number that describes how much of the query sequence is covered by the target sequence. If the target sequence in the database spans the whole query sequence, then the query cover is 100%. This tells us how long the sequences are, relative to each other. FASTA format FASTA format is used to represent either nucleotide or peptide sequences.
    [Show full text]